These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 125593)
41. Natural killer (NK) cell activity of peripheral blood, synovial fluid, and synovial tissue lymphocytes from patients with rheumatoid arthritis and juvenile rheumatoid arthritis. Dobloug JH; Førre O; Kvien TK; Egeland T; Degré M Ann Rheum Dis; 1982 Oct; 41(5):490-4. PubMed ID: 6181746 [TBL] [Abstract][Full Text] [Related]
42. TCR repertoire sequencing identifies synovial Treg cell clonotypes in the bloodstream during active inflammation in human arthritis. Rossetti M; Spreafico R; Consolaro A; Leong JY; Chua C; Massa M; Saidin S; Magni-Manzoni S; Arkachaisri T; Wallace CA; Gattorno M; Martini A; Lovell DJ; Albani S Ann Rheum Dis; 2017 Feb; 76(2):435-441. PubMed ID: 27311837 [TBL] [Abstract][Full Text] [Related]
43. In vitro mitogen stimulation of synovial fluid lymphocytes from rheumatoid arthritis and juvenile rheumatoid arthritis patients: dissociation between the response to antigens and polyclonal mitogens. Abrahamsen TG; Frøland SS; Natvig JB Scand J Immunol; 1978; 7(1):81-90. PubMed ID: 345418 [TBL] [Abstract][Full Text] [Related]
44. [Pathogenesis of complement decrease in the synovial fluid in rheumatoid arthritis and disseminated lupus erythematosus]. Peltier AP; de Sèze S Rev Rhum Mal Osteoartic; 1971 Jan; 38(1):61-8. PubMed ID: 5549169 [No Abstract] [Full Text] [Related]
45. Surface markers on human B and T lymphocytes. V. Characterization of the lymphoproliferative response to three different lectins and allogeneic lymphocytes by surface markers. Jondal M Scand J Immunol; 1974; 3(6):749-55. PubMed ID: 4549134 [No Abstract] [Full Text] [Related]
46. Autologous and allogeneic MLC-reactivity in patients with rheumatoid arthritis. Beck P; Burmester GR; Ledwoch A; Urban C; Kalden JR J Clin Lab Immunol; 1981 Jul; 6(1):27-33. PubMed ID: 6455522 [TBL] [Abstract][Full Text] [Related]
47. Antibody-dependent direct cytotoxicity of human lymphocytes. II. Studies on peripheral blood lymphocytes, synovial fluid cells and sera from patients with rheumatoid arthritis. Scheinberg MA; Cathcart ES Clin Exp Immunol; 1976 May; 24(2):323-7. PubMed ID: 1084244 [TBL] [Abstract][Full Text] [Related]
48. Stimulatory capacity of human T and B lymphocytes in the mixed leukocyte culture. Lohrmann HP; Novikovs L; Graw RG Nature; 1974 Jul; 250(462):144-6. PubMed ID: 4135582 [No Abstract] [Full Text] [Related]
49. Characterisation of blood and synovial fluid lymphocytes from patients with rheumatoid arthritis and other joint diseases by monoclonal antibodies (OKT series) and acid alpha-naphthyl esterase staining. Duclos M; Zeidler H; Liman W; Pichler WJ; Rieber P; Peter HH Rheumatol Int; 1982; 2(2):75-82. PubMed ID: 6217535 [TBL] [Abstract][Full Text] [Related]
50. Lymphocyte surface immunoglobulins in autoimmune diseases. Gergely P; Szegedi G; Fekete B; Szabó G; Petrányi G Lancet; 1973 Mar; 1(7801):482-3. PubMed ID: 4120390 [No Abstract] [Full Text] [Related]
51. Expression of the CD2 activation epitope T11-3 (CD2R) on T cells in rheumatoid arthritis, juvenile rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, and Lyme disease: phenotypic and functional analysis. Potocnik AJ; Menninger H; Yang SY; Pirner K; Krause A; Burmester GR; Bröker BM; Hept P; Weseloh G; Michels H Scand J Immunol; 1991 Sep; 34(3):351-8. PubMed ID: 1715605 [TBL] [Abstract][Full Text] [Related]
52. Markers of activated T cells on synovial fluid lymphocytes in rheumatoid arthritis. Mathieu A Boll Ist Sieroter Milan; 1979 Jan; 57(6):774-8. PubMed ID: 317895 [TBL] [Abstract][Full Text] [Related]
53. [Serum complement and synovial complement. Respective variations in rheumatic pathology]. Kourilsky O; Peltier AP; de Sèze S Nouv Presse Med; 1972 Jun; 1(26):1769-76. PubMed ID: 4538278 [No Abstract] [Full Text] [Related]
54. Chronic lymphocytic leukemia cells: rosette formation and adherence to nylon fiber columns. Aisenberg AC; Long JC; Wilkes B J Natl Cancer Inst; 1974 Jan; 52(1):13-7. PubMed ID: 4544025 [No Abstract] [Full Text] [Related]
55. HLA-DR positive T lymphocytes in blood and synovial fluid in rheumatoid arthritis. Kluin-Nelemans HC; van der Linden JA; Gmelig Meyling FH; Schuurman HJ J Rheumatol; 1984 Jun; 11(3):272-6. PubMed ID: 6610750 [TBL] [Abstract][Full Text] [Related]
56. [T- and B-lymphocytes of the peripheral blood and synovial fluid in patients with rheumatoid arthritis]. Arustamova RG; Bolotin EV; Gordovskaia NB; Krel' AA; Traianova TG Ter Arkh; 1976; 48(8):41-4. PubMed ID: 1088223 [No Abstract] [Full Text] [Related]
57. [Clinical and immunological parameters of rheumatoid arthritis as basis for assessment of activity and follow up of the course of the disease (author's transl)]. Frank O Wien Klin Wochenschr Suppl; 1974; 30():1-22. PubMed ID: 4547890 [No Abstract] [Full Text] [Related]
59. [Determination of B and T lymphocytes in human peripheral blood]. Nowak J Pol Arch Med Wewn; 1974 Jun; 52(1):21-30. PubMed ID: 4546603 [No Abstract] [Full Text] [Related]
60. Serum and synovial fluid inhibitors of antibody-mediated lymphocytotoxicity in rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum; 1976; 19(2):142-9. PubMed ID: 56939 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]